HYDROMORPHONE HCL ER 8 MG TAB

hydromorphone hydrochloride
$6.3646per EA
High Outlier
DEA Schedule CII

Strength

8 mg/1

Manufacturer

Padagis US LLC

NDC

00574029301

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

HYDROMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204278

On Market Since

5/22/2015

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

-9.3%

3M

-0.6%

6M

-0.6%

1Y

-9.1%

3Y

-9.1%

5Y

-9.1%

All

-41.3%